MERIT MEDICAL SYSTEMS INC
Close on Oct 19, 2026
- Market cap
- $5.40B
- P/E (TTM)
- 37.2
- Dividend yield
- –
About Merit Medical Systems
Surgical & Medical Instruments & Apparatus, SIC 3841
Merit Medical Systems, Inc. designs, develops, and manufactures medical devices used in interventional, diagnostic, and therapeutic procedures. The company operates through two primary segments: cardiovascular and endoscopy. Its cardiovascular offerings include catheters, guide wires, introducer sheaths, embolotherapy products, biopsy systems, fluid management tools, and spine intervention devices, along with contract manufacturing services for original equipment manufacturers. Its endoscopy segment provides pulmonary and gastrointestinal devices such as esophageal stents and dilation balloons. The company sells its products to hospitals, acute care facilities, and healthcare professionals, including physicians, technicians, and nurses.
Headquartered in South Jordan, Utah, the company operates eleven manufacturing facilities located in the United States, Mexico, Brazil, Ireland, France, the Netherlands, and Singapore. It maintains research and development operations in the United States, Ireland, and France. The company distributes its products worldwide through distribution centers in North America, South America, Europe, Africa, Asia, and Oceania, supported by direct sales teams and more than 500 distributors in China.
Summary of the business section of Merit Medical Systems's latest annual report, written by StockData.
Company profile
Company
- Legal name
- MERIT MEDICAL SYSTEMS INC
- Founded
- 1987
- Headquarters
- South Jordan, UT
- Address
- 1600 West Merit Park Way 84095
- Phone
- (801) 253-1600
- Website
- merit.com
- Employees
- 7,500, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Utah
- Fiscal year ends
- December 31
- Auditor
- DELOITTE & TOUCHE LLP, Salt Lake City, Utah
Stock & identifiers
- Ticker
- MMSI
- Exchange
- Nasdaq
- IPO date
- May 14, 1990
- Shares outstanding
- 60M, Jul 28, 2026
- Public float
- $5.40B, Jun 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 5-for-4, May 6, 2011; 4-for-3, Dec 3, 2003; 4-for-3, Aug 15, 2003; 5-for-4, Apr 12, 2002; 5-for-4, Aug 28, 2001; 3-for-2, Jul 16, 1991
- SEC CIK
- 856982
- CUSIP
- 589889104
- ISIN
- US5898891040
- LEI
- 549300OYTY138SP2CE83
- EIN
- 87-0447695
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Martha Goldberg Aronson | President and CEO, Director | 49,792 |
| Sheri Lewis | EVP of Global Operations | 8,371 |
| Neil W. Peterson | CHIEF OPERATING OFFICER | 18,051 |
| Michel J. Voigt | CHIEF HUMAN RESOURCES OFFICER | 47,677 |
| Brian G. Lloyd | CHIEF LEGAL OFFICER, SECRETARY | 62,132 |
| Christian Adam Smith | Chief Commercial Officer | 32,554 |
| Raul Parra Jr. | CFO AND TREASURER | 61,542 |
| Thomas J. Gunderson | Director | 60,741 |
| F. Ann Ed.D. Millner | Director | 38,000 |
| Michael R. McDonnell | Director | 9,852 |
| Lonny J. Carpenter | Director | 20,824 |
| Lynne N. Ward | Director | 11,266 |
| Stephen C. Evans | Director | 10,266 |
| Laura S. Kaiser | Director | 13,352 |
| Scott R. Ward | Director | 3,457 |
| Silvia M. Perez | Director | 8,040 |
| Fred P. Lampropoulos | Director | 1,126,457 |
| David Floyd | Director | 15,066 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Fred P.Lampropoulos | $13.76M | $9.88M | $4.18M | $159 | $100 |
| FY2025 Martha G.Aronson | $6.73M | $7.07M | $4.18M | $159 | $100 |
| FY2024 Fred P. Lampropoulos | $10.38M | $16.38M | $3.20M | $174 | $99 |
| FY2024 Fred P.Lampropoulos | $10.38M | $16.38M | $3.20M | $174 | $99 |
| FY2023 Fred P. Lampropoulos | $10.05M | $9.80M | $2.74M | $137 | $86 |
| FY2023 Fred P.Lampropoulos | $10.05M | $9.80M | $2.74M | $137 | $86 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had approximately 7,500 employees located in approximately 43 countries performing a variety of roles.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| May 1, 2019 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Nov 14, 2018 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Feb 21, 2018 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jul 6, 2016 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Dec 24, 2012 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Sep 28, 2011 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Sep 16, 2010 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Sep 10, 2010 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jun 8, 2009 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Mar 16, 2009 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |